Hangzhou Alltest Biotech Co., Ltd.

Hangzhou Alltest Biotech Co., Ltd. (688606.SS) is a China-based healthcare company founded in 2009 and headquartered in Hangzhou, specializing in the research, development, production, and sale of in vitro diagnostic (IVD) reagents for both domestic and international markets. The company's core product portfolio consists of rapid diagnostic reagents spanning key health sectors, including women's health, infectious disease detection, drug and drug abuse screening, tumor markers, and cardiac markers, with notable offerings such as COVID-19 antigen and antibody tests, fluorescence immunoassay tests and analyzers, and veterinary test products. Operating under its primary brands — Alltest, Juscheck, and Beright — the company leverages advanced biological technologies including monoclonal antibody-colloidal gold, latex technique, gene engineering, and immunochromatography to deliver rapid, accurate, and convenient point-of-care testing (POCT) solutions. Listed on the Shanghai Stock Exchange in March 2021, Hangzhou Alltest Biotech generated approximately CNY 882 million in trailing twelve-month revenue and employs over 1,000 staff, with its business predominantly distributed across overseas markets worldwide.